A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer

Abstract

In TNBC, the CLDN1-negative phenotype predicts a high risk of recurrence and death. The absence of CLDN1 expression is strongly suggested to be an independent adverse prognostic factor in this heterogeneous subtype of breast cancer.